Riordan, Lewis & Haden has sold its portfolio company Cymetrix Corporation, a provider of revenue cycle management services to hospitals, to Navigant for $75 million. Riordan, Lewis & Haden first invested in Cymetrix in June 2005.
Cymetrix is a provider of outsourced business services to major for-profit, faith-based, and community hospital systems. The company serves over 200 hospitals nationwide. Cymetrix helps its clients improve speed, accuracy, and effectiveness at each stage in the hospital revenue cycle, including gathering patient data, coding medical records, and collecting receivables. Cymetrix is headquartered in Irvine, CA (www.cymetrix.com).
Riordan, Lewis & Haden invests in high growth, lower middle market companies that have revenues from $20 million to $150 million. Sectors of interest include business services, healthcare, and government services. The firm currently manages over $600 million of assets and is actively seeking new portfolio companies. Riordan, Lewis & Haden is based in Los Angeles (www.rlhequity.com).
Navigant (NYSE: NCI) is a specialized expert services firm that assists clients in creating and protecting value in the face of business risks and opportunities. 2012 revenues were $845 million and the company has over forty offices across the United States, Canada, Europe, and Asia. Navigant is headquartered in Chicago (www.navigant.com).
© 2014 PEPD • Private Equity’s Leading News Magazine • 5-16-14